---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-001382"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2022-10-25T23:59:59+00:00"
generated_at: "2026-06-23T01:31:44.962996+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# USANA Q3 sales $233M (-15% YoY), EPS $0.78; slashes FY2022 guidance

## Summary
- Net sales $233M, down 15% YoY ($274M); diluted EPS $0.78 vs $1.36, down 43%.
- Active customers fell 18% to 474,000; Asia Pacific region sales down 17% constant currency.
- FY2022 outlook cut: net sales $955-975M (prev. $1,015-1,065M); EPS $3.15-3.40 (prev. $3.85-4.45).
- Operating cash flow $29M; cash $247M, debt-free; no share repurchases in quarter.
- Management cites COVID disruptions in Asia, stronger USD headwind of ~$15M (6% of sales).

## SEC filing metadata
- accession: 0001157523-22-001382
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2022-10-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000115752322001382/0001157523-22-001382-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000115752322001382/a52952545.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-001382
- JSON: https://secwatch.observer/filing/0001157523-22-001382.json
- Plain text: https://secwatch.observer/filing/0001157523-22-001382.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.